Dr Amit Singal on the Improving Outlook for HCC and How to Choose Treatments

Amit Singal, MD, medical director of the Liver Tumor Program at UT Southwestern Medical Center, discussed the current outlook for patients with hepatocellular carcinoma (HCC) and how to choose between therapies.

Related Keywords

Ramit Singal ,Ut Southwestern Medical Center ,Liver Tumor Program ,Medical Center ,